+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07214753

Italian Multicenter Observational Study Evaluating Clinical Remission and Immunomodulation in Adults with Severe Eosinophilic Asthma Treated with Benralizumab - The ATHENA Study

Led by AstraZeneca · Updated on 2026-09-18

335

Participants Needed

28

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting an observational, multicenter, prospective study to evaluate the effects of benralizumab in adult patients with severe eosinophilic asthma. The study focuses on assessing the achievement of partial and complete clinical remission as defined by the Severe Asthma Network in Italy SANI. It also aims to deepen understanding of benralizumabs immunological effects and contribute to knowledge about asthma pathophysiology while consolidating long-term safety data. Participants in this study are patients treated with benralizumab, administered as 30mg subcutaneous injections according to the approved prescribing information. The study observes patients who have started or are about to start benralizumab treatment within a specific timeframe around enrollment. This real-life study does not involve assigning treatments but follows patients receiving benralizumab in clinical practice. During the study, participants will be monitored over up to 24 months to track clinical remission rates, asthma exacerbations, lung function changes, asthma control test scores, and medication use. Various assessments including lung function tests and questionnaires will be collected at baseline and multiple time points throughout the follow-up. The study aims to provide detailed real-world data on benralizumabs role in managing severe eosinophilic asthma.

CONDITIONS

Brief Title

A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

Research Team

A

AstraZeneca Clinical Study Information Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here